Profound transient thrombocytopenia associated with 90Yttrium microsphere therapy for inoperable hepatoma

Southern Medical Journal

Volumn 103, Issue 12, 2010, Pages 1264-1268

  Yang, Chia Wei ^a,b   Yen, Hsu Heng ^a,b   Su, Wei Wen ^a,b   Chen, Yang Yuan ^a,b   Soon, Maw Soan ^a,b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

90Yttrium microspheres; bone marrow suppression; hepatoma; thrombocytopenia

Indexed keywords

ALPHA FETOPROTEIN; HEMOGLOBIN; HEPATITIS C ANTIBODY; MACROSALB TC 99M; MICROSPHERE Y 90; RADIOACTIVE MICROSPHERE; SIR SPHERES; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG; YTTRIUM 90;

ABDOMINAL PAIN; ADVANCED CANCER; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING; BLOOD CELL COUNT; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; CANCER RADIOTHERAPY; CASE REPORT; CELIAC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; GASTRODUODENAL ARTERY; GASTROINTESTINAL TRACT; HEPATIC ARTERY; HEPATITIS C; HUMAN; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; MALE; PORTAL VEIN THROMBOSIS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TUMOR BIOPSY; TUMOR VASCULARIZATION; WEIGHT REDUCTION;

AGED; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; THROMBOCYTOPENIA; YTTRIUM RADIOISOTOPES;

EID: 78650418035     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181fa5ec7     Document Type: Article

References (20)

1. Beheshti MV, Denny DF Jr, Glickman MG, et al. Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report. J Vasc Interv Radiol 1992;3:453-458.
2. Wharton JT, Delclos L, Gallager S, et al. Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med 1973;117:73-80.
3. Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 2000;45:1023-1033.
4. Lau WY, Leung WT, Ho S, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 1994;70:994-999.
5. Salem R, Lewandowski RJ, Atassi B, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 2005;16: 1627-1639.
6. Kulik LM, Atassi B, van Holsbeeck L, et al. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 2006;94:572-586.
7. Szyszko T, Al-Nahhas A, Tait P, et al. Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres. Nucl Med Commun 2007;28:21-24.
8. Leung TW, Lau WY, Ho SK, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 1995;33:919-924.
9. Carretero C, Munoz-Navas M, Betes M, et al. Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol 2007; 102:1216-1220.
10. Murthy R, Brown DB, Salem R, et al. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 2007;18:553-561; quiz 562.
11. South CD, Meyer MM, Meis G, et al. Yttrium-90 microsphere induced gastrointestinal tract ulceration. World J Surg Oncol 2008;6:93.
12. Ogawa F, Mino-Kenudson M, Shimizu M, et al. Gastroduodenitis associated with yttrium 90-microsphere selective internal radiation: an iatrogenic complication in need of recognition. Arch Pathol Lab Med 2008; 132:1734-1738.
13. Thamboo TP, Wai CT, Lim LG, et al. Late gastric ulceration and cytomegalovirus infection following selective internal radiation therapy (SIRT) of the liver. Pathology 2008;40:303-305.
14. Konda A, Savin MA, Cappell MS, et al. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity. Gastrointest Endosc 2009;70:561-567.
15. Ng SS, Yu SC, Lai PB, et al. Biliary complications associated with selective internal radiation (SIR) therapy for unresectable liver malignancies. Dig Dis Sci 2008;53:2813-2817.
16. Nalesnik MA, Federle M, Buck D, et al. Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma. Hum Pathol 2009;40:125-134.
17. Salem R, Parikh P, Atassi B, et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol 2008;31:431-438.
18. Carr BI. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004;10(2 Suppl 1):S107-S110.
19. Mantravadi RV, Spigos DG, Tan WS, et al. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 1982;142:783-786.
20. Novell JR, Hilson A, Hobbs KE. Therapeutic aspects of radio-isotopes in hepatobiliary malignancy. Br J Surg 1991;78:901-906.